Cellectar Biosciences, Inc. (CLRB) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 9.27M | 14.04M | 13.62M | 12.62M | 14.89M | 24.25M | 35.9M | 27.91M | 41.37M | 10.45M | 20.11M | 5.61M | 13.85M | 20.53M | 18.76M | 25.29M | 31.39M | 36.57M | 41.39M | 47.12M |
| Cash & Short-Term Investments | 8.35M | 13.2M | 12.55M | 11.04M | 13.91M | 23.29M | 34.26M | 25.87M | 40.03M | 9.56M | 18.99M | 5.15M | 12.68M | 19.87M | 17.79M | 24.81M | 30.63M | 35.7M | 40.34M | 46.78M |
| Cash Only | 8.35M | 13.2M | 12.55M | 11.04M | 13.91M | 23.29M | 34.26M | 25.87M | 40.03M | 9.56M | 18.99M | 5.15M | 12.68M | 19.87M | 17.79M | 24.81M | 30.63M | 35.7M | 40.34M | 46.78M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 920.04K | 842.43K | 0 | 0 | 987.5K | 961.66K | 1.64M | 2.04M | 1.34M | 888.23K | 1.12M | 456.68K | 1.16M | 663.24K | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 1.85M | 939.86K | 1.01M | 1.08M | 1.15M | 1.22M | 1.39M | 1.48M | 1.54M | 1.62M | 1.44M | 899.51K | 992.02K | 1.06M | 558.25K | 607.16K | 595.64K | 630.35K | 560.46K | 612.98K |
| Property, Plant & Equipment | 1.82M | 910.08K | 976.11K | 1.05M | 1.12M | 1.19M | 1.36M | 1.45M | 1.51M | 1.59M | 1.41M | 869.73K | 922.59K | 978.98K | 477.04K | 525.95K | 514.43K | 549.13K | 479.25K | 531.76K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K | 69.43K | 81.21K | 81.21K | 81.21K | 81.21K | 81.21K | 81.21K | 81.21K |
| Total Assets | 11.12M | 14.98M | 14.63M | 13.7M | 16.04M | 25.47M | 37.29M | 29.38M | 42.91M | 12.08M | 21.55M | 6.51M | 14.84M | 21.59M | 19.32M | 25.89M | 31.99M | 37.2M | 41.95M | 47.74M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -30.68% | -41.2% | -60.78% | -53.39% | -62.61% | 110.96% | 73.05% | 351.44% | 189.17% | -44.07% | 11.55% | -74.86% | -53.62% | -41.97% | -53.95% | -45.76% | -41.9% | -36.58% | 102.71% | 100.14% |
| Total Current Liabilities | 4.87M | 4.75M | 4.91M | 5.87M | 6.02M | 9.39M | 20.31M | 15.17M | 28.55M | 25.36M | 16.47M | 6.45M | 6.96M | 11.5M | 6.52M | 5.61M | 4.65M | 3.99M | 3.17M | 3.52M |
| Accounts Payable | 4.72M | 4.42M | 4.01M | 4.68M | 3.87M | 4.11M | 8.3M | 6.46M | 7.39M | 9.18M | 0 | 6.39M | 6.9M | 5.48M | 6.37M | 5.46M | 4.51M | 3.85M | 3.03M | 3.39M |
| Days Payables Outstanding | -3.74K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 100.19K | 0 | 0 | 0 | 0 | 0 | 0 | 73.99K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 149K | 226K | 801.65K | 1.1M | 2.06M | 4.59M | 11.93M | 8.63M | 21.08M | 16.12M | 16.41M | 0 | 0 | 5.97M | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 1.90x | 2.96x | 2.77x | 2.15x | 2.47x | 2.58x | 1.77x | 1.84x | 1.45x | 0.41x | 1.22x | 0.87x | 1.99x | 1.78x | 2.88x | 4.51x | 6.75x | 9.16x | 13.07x | 13.39x |
| Quick Ratio | 1.90x | 2.96x | 2.77x | 2.15x | 2.47x | 2.58x | 1.77x | 1.84x | 1.45x | 0.41x | 1.22x | 0.87x | 1.99x | 1.78x | 2.88x | 4.51x | 6.75x | 9.16x | 13.07x | 13.39x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.53M | 309.4K | 335.89K | 361.49K | 1.77M | 1.79M | 1.81M | 453.51K | 474.35K | 494K | 18.43M | 530.86K | 548.34K | 552.98K | 53.77K | 92.21K | 129.71K | 166.29K | 201.97K | 236.06K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 1.53M | 309.4K | 335.89K | 361.49K | 386.2K | 409.59K | 431.93K | 453.51K | 474.35K | 494K | 512.75K | 530.86K | 548.34K | 552.98K | 53.77K | 92.21K | 129.71K | 166.29K | 201.97K | 236.06K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 1.38M | 1.38M | 1.38M | 0 | 0 | 0 | 17.92M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 6.4M | 5.06M | 5.25M | 6.23M | 7.79M | 11.18M | 22.13M | 15.62M | 29.03M | 25.85M | 34.9M | 6.98M | 7.5M | 12.05M | 6.57M | 5.7M | 4.78M | 4.16M | 3.37M | 3.75M |
| Total Debt | 1.53M | 409.59K | 431.93K | 453.51K | 474.35K | 494K | 512.75K | 530.86K | 548.34K | 552.98K | 569.01K | 584.5K | 599.45K | 603.83K | 201.97K | 236.06K | 269.31K | 301.74K | 333.38K | 363.53K |
| Net Debt | -6.82M | -12.79M | -12.12M | -10.59M | -13.43M | -22.79M | -33.75M | -25.34M | -39.48M | -9.01M | -18.42M | -4.57M | -12.08M | -19.26M | -17.58M | -24.57M | -30.36M | -35.4M | -40.01M | -46.41M |
| Debt / Equity | 0.32x | 0.04x | 0.05x | 0.06x | 0.06x | 0.03x | 0.03x | 0.04x | 0.04x | - | - | - | 0.08x | 0.06x | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 4.72M | 9.92M | 9.38M | 7.47M | 8.25M | 14.29M | 15.16M | 13.76M | 13.88M | -13.78M | -13.35M | -467K | 7.33M | 9.54M | 12.75M | 20.19M | 27.21M | 33.05M | 38.59M | 43.98M |
| Equity Growth % | -42.85% | -30.61% | -38.15% | -45.75% | -40.55% | 203.76% | 213.57% | 3047.08% | 89.29% | -244.48% | -204.72% | -102.31% | -73.04% | -71.14% | -66.96% | -54.09% | -45.34% | -39.69% | 137.83% | 120.08% |
| Book Value per Share | 1.11 | 2.34 | 2.97 | 4.64 | 5.37 | 10.23 | 11.57 | 11.03 | 14.19 | -21.28 | -35.42 | -1.24 | 19.54 | 30.74 | 62.60 | 99.15 | 133.59 | 162.25 | 193.35 | 250.08 |
| Total Shareholders' Equity | 4.72M | 9.92M | 9.38M | 7.47M | 8.25M | 14.29M | 15.16M | 13.76M | 13.88M | -13.78M | -13.35M | -467K | 7.33M | 9.54M | 12.75M | 20.19M | 27.21M | 33.05M | 38.59M | 43.98M |
| Common Stock | 42 | 42 | 32 | 18 | 461 | 461 | 406 | 358 | 332 | 207 | 99 | 97 | 97 | 94 | 61 | 61 | 611 | 611 | 611 | 553 |
| Retained Earnings | -274.79M | -269.13M | -263.84M | -259.39M | -253.95M | -247.34M | -244.99M | -230.32M | -229.4M | -202.76M | -210.03M | -196.3M | -188.08M | -159.99M | -172.28M | -164.47M | -157.04M | -150.9M | -144.98M | -139.16M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |